Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Editorial

Clinical impact of five cardiometabolic risk factors in metabolic dysfunction-associated steatotic liver disease (MASLD): Insights into regional and ethnic differences

Joo Hyun Oh, Dae Won Jun

Clin Mol Hepatol. 2024;30(2):168-170. Published online March 5, 2024

DOI: https://doi.org/10.3350/cmh.2024.0140

View: 2376 Download: 72 Web of Science: 1 Crossref: 2

Special Review

Waiting for the changes after the adoption of steatotic liver disease

Eileen L. Yoon, Dae Won Jun

Clin Mol Hepatol. 2023;29(4):844-850. Published online September 6, 2023

DOI: https://doi.org/10.3350/cmh.2023.0291

View: 2817 Download: 172 Web of Science: 15 Crossref: 21

Editorial

Non-obese or lean nonalcoholic fatty liver disease matters, but is it preventable or inevitable in light of its risk factors?

Heejoon Jang, Won Kim

Clin Mol Hepatol. 2023;29(2):381-383. Published online March 9, 2023

DOI: https://doi.org/10.3350/cmh.2023.0088

View: 3215 Download: 91 Web of Science: 2 Crossref: 3

Letter to the Editor

Correspondence on Letter regarding “Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis”

Tae Hyung Kim, Young Kul Jung, Hyung Joon Yim

Clin Mol Hepatol. 2023;29(1):173-175. Published online November 15, 2022

DOI: https://doi.org/10.3350/cmh.2022.0372

View: 3055 Download: 45 Web of Science: 1 Crossref: 1

Original Article

Outcomes after liver transplantation in Korea: Incidence and risk factors from Korean transplantation registry

Jong Man Kim, Deok Gie Kim, Jihyun Kim, Keunsung Lee, Kwang-Woong Lee, Je Ho Ryu, Bong-Wan Kim, Dong Lak Choi, Young Kyoung You, Dong-Sik Kim, Yang Won Nah, Koo Jeong Kang, Jai Young Cho, Geun Hong, Hee Chul Yu, Ju Ik Moon, Dongho Choi, Shin Hwang, Myoung Soo Kim

Clin Mol Hepatol. 2021;27(3):451-462. Published online February 2, 2021

DOI: https://doi.org/10.3350/cmh.2020.0292

View: 7763 Download: 318 Web of Science: 34 Crossref: 37

Special topic: Alcoholic liver diseases The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)

Alcohol and hepatocarcinogenesis

Makiko Taniai

Clin Mol Hepatol. 2020;26(4):736-741. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0203

View: 6918 Download: 192 Web of Science: 34 Crossref: 32

Review

Factors affecting drug-induced liver injury: antithyroid drugs as instances

Reza Heidari, Hossein Niknahad, Akram Jamshidzadeh, Narges Abdoli

Clin Mol Hepatol. 2014;20(3):237-248. Published online September 25, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.3.237

View: 17989 Download: 336 Web of Science: 38 Crossref: 43

Original Article

Predictive factors that influence the survival rates in liver cirrhosis patients with spontaneous bacterial peritonitis

Pei Chuan Tsung, Soo Hyung Ryu, In Hye Cha, Hee Won Cho, Jin Nam Kim, You Sun Kim, Jeong Seop Moon

Clin Mol Hepatol. 2013;19(2):131-139. Published online June 27, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.2.131

View: 9282 Download: 97 Crossref: 32

3

Natural history of gastric varices and risk factors for bleeding

Choong Hyeon Lee, M.D., Joon Hyoek Lee, M.D., Ph.D., Yong Sung Choi, M.D., Seung Woon Paik, M.D., Dong Hyun Sinn, M.D., Choon Young Lee, M.D., Kwang Cheol Koh, M.D., Geum-Youn Gwak, M.D., Moon Seok Choi, M.D., Byung Chul Yoo, M.D.

Clin Mol Hepatol. 2008;14(3):331-341. Published online September 30, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.3.331

View: 4958 Download: 76 Crossref: 12

Risk Factors of Morbidity and Mortality Following Surgical Resection for Hepatocellular Carcinoma

Wan Wook Kim, M.D., Kwang-Woong Lee, M.D., Sung Ho Choi, M.D., Jin Seok Heo, M.D., Yong Il Kim, M.D., Sung Ju Kim, M.D., Dae Sung Lee, M.D., Hwan Hyo Lee, M.D., Seung Woon Paik, M.D. Kwang Cheol Koh, M.D. Joon Hyoek Lee, M.D. Moon Seok Choi, M.D. , Byung Chul Yoo, M.D. and Jae Won Joh, M.D.

Clin Mol Hepatol. 2004;10(1):51-61. Published online January 1, 1970

View: 3008 Download: 20

Establishment of Individual Prediction Model According to Risk Factorsfor Development of Hepatocellular Carcinoma in Korea : Establishment of Individual Prediction Model for Hepatocellular Carcinoma

Jae Youn Cheong, M.D., Kwang-Hyub Han, M.D., Dong Kee Kim, Ph.D.*, Sang Hoon Ahn, M.D., Ki Jun Song, M.S.*, Yong Han Paik, M.D., Chang Hwan Choi, M.D., Hyun Woong Lee, M.D., Young Soo Park, M.D., Chae Yoon Chon, M.D., and Young Myoung Moon, M.D.,

Clin Mol Hepatol. 2001;7(4):449-458. Published online January 1, 1970

View: 2297 Download: 18

1 |

Viewed By 5160	MAFLD: How is it different from NAFLD?
Viewed By 4906	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4875	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 4596	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 4571	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 219	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 155	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 134	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 119	MAFLD: How is it different from NAFLD?
Cited By 96	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search